Načítá se...
MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study
BACKGROUND: A substantial impediment to progress in trials of new therapies in neuromuscular disorders is the absence of responsive outcome measures that correlate with patient functional deficits and are sensitive to early disease processes. Irrespective of the primary molecular defect, neuromuscul...
Uloženo v:
| Vydáno v: | Lancet Neurol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lancet Pub. Group
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4672173/ https://ncbi.nlm.nih.gov/pubmed/26549782 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(15)00242-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|